ESC 365 - Will SGLT2 inhibitor prevent the need for IV iron?

HFA Premium Access

Will SGLT2 inhibitor prevent the need for IV iron?

Session: Significant but poorly addressed issues in heart failure

Topic: Chronic Heart Failure

Speaker: Professor L. Rohde (Porto Alegre, BR)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Professor Luis Eduardo Rohde

Universidade Federla do Rio Grande do Sul, Porto Alegre (Brazil)

3 presentations

0 follower

3 more presentations in this session

The impact of Flu vaccine in patients with heart failure

Speaker: Professor M. Tavares de Oliveira Junior (Sao Paulo, BR)

Natural Peptides and artificial intelligence to improve risk prediction

Speaker: Professor H. Brunner-La Rocca (Maastricht, NL)

Discussion - Significant but poorly addressed issues in heart failure

Access the full session

Significant but poorly addressed issues in heart failure

Speakers: Professor L. Rohde, Professor M. Tavares de Oliveira Junior, Professor H. Brunner-La Rocca

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources